Have a personal or library account? Click to login
Influence of different formulations and process parameters during the preparation of drug-loaded PLGA microspheres evaluated by multivariate data analysis Cover

Influence of different formulations and process parameters during the preparation of drug-loaded PLGA microspheres evaluated by multivariate data analysis

Open Access
|Dec 2014

References

  1. 1. D. Klose, F. Siepmann, J. F. Willart, M. Descamps and J. Siepmann, Drug release from PLGA-based microparticles: Effects of the “microparticle:bulk fluid” ratio, Int. J. Pharm. 383 (2010) 123-131; DOI: 10.1016/j.ijpharm.2009.09.012.10.1016/j.ijpharm.2009.09.012
  2. 2. C. Regnier-Delplace, O. Thillaye Du Boullay, F. Siepmann, B. Martin-Vaca, N. Degrave, P. Demonchaux, O. Jentzer, D. Bourissou and J. Siepmann, PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine, Int. J. Pharm. 443 (2013) 68-79; DOI: 10.1016/j. ijpharm.2013.01.008.
  3. 3. C. Wischke and S. P. Schwendeman, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, Int. J. Pharm. 364 (2008) 298-327; DOI: 10.1016/j.ijpharm.2008.04.042.10.1016/j.ijpharm.2008.04.042
  4. 4. D. Klose, C. Delplace and J. Siepmann, Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles, Int. J. Pharm. 404 (2011) 75-82; DOI: 10.1016/j.ijpharm.2010.10.054.10.1016/j.ijpharm.2010.10.054
  5. 5. D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin and J. Siepmann, How porosity and size affect the drug release mechanisms from PLGA-based microparticles, Int. J. Pharm. 314 (2006) 198-206; DOI: 10.1016/j.ijpharm.2005.07.031.10.1016/j.ijpharm.2005.07.031
  6. 6. S. Freitas, H. P. Merkle and B. Gande, Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology, J. Control. Release 102 (2005) 313-332; DOI: 10.1016/j.jconrel.2004.10.015.10.1016/j.jconrel.2004.10.015
  7. 7. I. D. Rosca, F. Watari and M. Uo, Microparticle formation and its mechanism in single and double emulsion solvent evaporation, J. Control. Release 99 (2004) 271-280; DOI: 10.1016/j.jconrel.2004.07.007.10.1016/j.jconrel.2004.07.007
  8. 8. G. Paskaris and N. Bouropoulos, Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads, Int. J. Pharm. 323 (2006) 34-42; DOI: 10.1016/j. ijpharm.2006.05.054.
  9. 9. S. B. Wang, A. Z. Chen, L. J. Weng, M. Y. Chen and X. L. Xie, Effect of drug-loading methods on drug load, encapsulation efficiency and release properties of alginate/poly-L arginine/chitosan ternary complex microcapsules, Macromol. Biosci. 4 (2004) 27-30; DOI: 10.1002/mabi.200300043.10.1002/mabi.200300043
  10. 10. M. Song, N. Li, S. Sun, L. R. Tiedt, W. Liebenberg and M. M. de Villiers, Effect of viscosity and concentration of wall former, emulsifier and pore-inducer on the properties of amoxicillin microcapsules prepared by emulsion solvent evaporation, Il. Farmaco. 60 (2005) 261-267; DOI: 10.1016/j. farmac.2004.11.009.
  11. 11. D. Vetchý, M. Vetchá, M. Rabišková, E. Gryczová and L. Bartošíková, Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug, Medicina (Kaunas). 43 (2007) 326-331.10.3390/medicina43040040
  12. 12. V. P. Shah, Y. Tsong, P. Sathe and J. P. Liu, In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2, Pharm. Res. 15 (1998) 889-896; DOI: 10.1023/A:1011976615750.10.1023/A:1011976615750
  13. 13. K. H. Esbensen, D. Guyot, F. Westad and L. P. Houmoller: Multivariate data analysis: in practice: an introduction to multivariate data analysis and experimental design, CAMO AS Publications, Oslo 2004, pp. 598.
  14. 14. P. Sansdrap and A. J. Moes, Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly (DL-lactide-co-glycolide) microspheres, Int. J. Pharm. 98 (1993) 157-164; DOI: 10.1016/0378-5173(93)90052-H.10.1016/0378-5173(93)90052-H
  15. 15. M. Hamoudeh and F. Hatem, Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles, J. Colloid. Interf. Sci. 300 (2006) 584-590; DOI: 10.1016/j. jcis.2006.04.024.
  16. 16. S. Tamilvanan, Effect of production variables on the physical characteristics of ibuprofen-loaded polystyrene microparticles, J. Microencapsul. 16 1999 411-418; DOI: 10.1080/026520499288870.10.1080/026520499288870
  17. 17. Y. Y. Yang, T. Chung and N. P. Ng, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method, Biomaterials 22 (2001) 231-241; DOI: 10.1016/S0142-9612(00)00178-2.10.1016/S0142-9612(00)00178-2
  18. 18. R. M. Mainardes and R. C. Evangelista, PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution, Int. J. Pharm. 290 (2005) 137-144; DOI: 10.1016/j. ijpharm.2004.11.027.
  19. 19. T. Freytag, A. Dashevsky, L. Tillman, G. E. Hardee and R. Bodmeier, Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres, J. Control. Release 69 (2000) 197-207; DOI: 10.1016/S0168-3659(00)00299-6.10.1016/S0168-3659(00)00299-6
  20. 20. P. B. O’Donnell and J. W. McGinity, Preparation of microspheres by the solvent evaporation technique, Adv. Drug Deliv. Rev. 28 (1997) 25-42; DOI: 10.1016/S0169-409X(97)00049-5. 10.1016/S0169-409X(97)00049-5
  21. 21. Y. Capan, B. H. Woo, S. Gebrekidan, S. Ahmed and P. P. DeLuca, Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA, J. Control. Release 60 (1999) 279-286; DOI: 10.1016/S0168-3659(99)00076-0.10.1016/S0168-3659(99)00076-0
  22. 22. S. Mao, Y. Shi, L. Li, J. Xu, A. Schaper and T. Kissel, Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method, Eur. J. Pharm. Biopharm. 68 (2008) 214-223; DOI: 10.1016/j. ejpb.2007.06.008.
  23. 23. M. Li, O. Rouaud and D. Poncelet, Microencapsulation by solvent evaporation: State of the art for process engineering approaches, Int. J. Pharm. 363 (2008) 26-39; DOI: 10.1016/j.ijpharm.2008.07.018.10.1016/j.ijpharm.2008.07.018
  24. 24. S. Fredenberg, M. Wahlgren, M. Reslow and A. Axelsson, The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - A review, Int. J. Pharm. 415 (2011) 34-52; DOI: 10.1016/j.ijpharm.2011.05.049.10.1016/j.ijpharm.2011.05.049
  25. 25. N. S. Berchane, K. H. Carson, A. C. Rice-Ficht and M. J. Andrews, Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory, Int. J. Pharm. 337 (2007) 118-126; DOI: 10.1016/j.ijpharm.2006.12.037.10.1016/j.ijpharm.2006.12.037
  26. 26. C. Berkland, K. Kim and D. W. Pack, PLG Microsphere size controls drug release rate through several competing factors, Pharmaceut. Res. 20 (2003) 1055-1062; DOI: 10.1023/A:1024466407849.10.1023/A:1024466407849
  27. 27. X. Huang and C. S. Brazel, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control. Release 73 (2001) 121-136. 10.1016/S0168-3659(01)00248-6
DOI: https://doi.org/10.2478/acph-2014-0032 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 403 - 417
Accepted on: Jun 16, 2014
Published on: Dec 20, 2014
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2014 Jakub Vysloužil, Petr Doležel, Martina Kejdušová, Eliška Mašková, Josef Mašek, Robert Lukáč, Vratislav Košťál, David Vetchý, Kateřina Dvořáčková, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.